植物miR395参与硫代谢调控,并在应答逆境胁迫等方面起重要调控作用.为了解香蕉miR395的分子特性和进化规律,在参考香蕉基因组信息的基础上,结合RT-PCR技术,从三明野生蕉（Musa itinerans）叶片中获得81 nt miR395a前体序列,包含21 nt mi...植物miR395参与硫代谢调控,并在应答逆境胁迫等方面起重要调控作用.为了解香蕉miR395的分子特性和进化规律,在参考香蕉基因组信息的基础上,结合RT-PCR技术,从三明野生蕉（Musa itinerans）叶片中获得81 nt miR395a前体序列,包含21 nt miR395a成熟体序列.进化特性分析表明,植物miR395a前体存在于27个物种中,野生蕉pre-miR395a序列与双子叶耧斗菜（Aquilegia viridiflora Pall.）最为接近,与单子叶的水稻、玉米、高粱最远,表明野生蕉pre-miR395a的起源比较特殊;前体序列长度差异较大（57-226 nt）;miR395a成熟体序列分析发现,来自5p臂上的miR395a序列特异性较大.野生蕉miR395a前体能形成典型的发卡结构,miR395a成熟体位于前体的3p臂上.转录起始位点分析表明,野生蕉pri-miR395a转录起始区域位于-87 bp--38 bp,A为转录起始位点.启动子顺式作用元件预测分析表明,野生蕉miR395a启动子包含多个激素、胁迫、生物钟及光响应元件,可能与响应胁迫密切相关.qPCR检测结果也发现miR395a的表达量在低温胁迫下极显著下调,表明响应低温胁迫.综上表明三明野生蕉在响应低温胁迫过程中miR395a起着重要调控作用,这对于进一步研究野生蕉miR395a在低温胁迫中的作用机制具有参考价值.展开更多
We previously reported that postsynaptic density-93 mediates neuron-microglia crosstalk by interacting with amino acids 357–395 of C-X3-C motif chemokine ligand 1(CX3 CL1) to induce microglia polarization. More impor...We previously reported that postsynaptic density-93 mediates neuron-microglia crosstalk by interacting with amino acids 357–395 of C-X3-C motif chemokine ligand 1(CX3 CL1) to induce microglia polarization. More importantly, the peptide Tat-CX3 CL1(comprising amino acids 357–395 of CX3 CL1) disrupts the interaction between postsynaptic density-93 and CX3 CL1, reducing neurological impairment and exerting a protective effect in the context of acute ischemic stroke. However, the mechanism underlying these effects remains unclear. In the current study, we found that the pro-inflammatory M1 phenotype increased and the anti-inflammatory M2 phenotype decreased at different time points. The M1 phenotype increased at 6 hours after stroke and peaked at 24 hours after perfusion, whereas the M2 phenotype decreased at 6 and 24 hours following reperfusion. We found that the peptide Tat-CX3 CL1(357–395 aa) facilitates microglial polarization from M1 to M2 by reducing the production of soluble CX3 CL1. Furthermore, the a disintegrin and metalloprotease domain 17(ADAM17) inhibitor GW280264 x, which inhibits metalloprotease activity and prevents CX3 CL1 from being sheared into its soluble form, facilitated microglial polarization from M1 to M2 by inhibiting soluble CX3 CL1 formation. Additionally, Tat-CX3 CL1(357–395 aa) attenuated long-term cognitive deficits and improved white matter integrity as determined by the Morris water maze test at 31–34 days following surgery and immunofluorescence staining at 35 days after stroke, respectively. In conclusion, Tat-CX3 CL1(357–395 aa) facilitates functional recovery after ischemic stroke by promoting microglial polarization from M1 to M2. Therefore, the Tat-CX3 CL1(357–395 aa) is a potential therapeutic agent for ischemic stroke.展开更多
基金supported by the National Natural Science Foundation of China,Nos. 82071304 (to QXZ), 81671149 (to QXZ),and 81971179 (to XML)the Natural Science Foundation of Jiangsu Province,Nos. BK20191463 (to XML) and BK20161167 (to QXZ)。
文摘We previously reported that postsynaptic density-93 mediates neuron-microglia crosstalk by interacting with amino acids 357–395 of C-X3-C motif chemokine ligand 1(CX3 CL1) to induce microglia polarization. More importantly, the peptide Tat-CX3 CL1(comprising amino acids 357–395 of CX3 CL1) disrupts the interaction between postsynaptic density-93 and CX3 CL1, reducing neurological impairment and exerting a protective effect in the context of acute ischemic stroke. However, the mechanism underlying these effects remains unclear. In the current study, we found that the pro-inflammatory M1 phenotype increased and the anti-inflammatory M2 phenotype decreased at different time points. The M1 phenotype increased at 6 hours after stroke and peaked at 24 hours after perfusion, whereas the M2 phenotype decreased at 6 and 24 hours following reperfusion. We found that the peptide Tat-CX3 CL1(357–395 aa) facilitates microglial polarization from M1 to M2 by reducing the production of soluble CX3 CL1. Furthermore, the a disintegrin and metalloprotease domain 17(ADAM17) inhibitor GW280264 x, which inhibits metalloprotease activity and prevents CX3 CL1 from being sheared into its soluble form, facilitated microglial polarization from M1 to M2 by inhibiting soluble CX3 CL1 formation. Additionally, Tat-CX3 CL1(357–395 aa) attenuated long-term cognitive deficits and improved white matter integrity as determined by the Morris water maze test at 31–34 days following surgery and immunofluorescence staining at 35 days after stroke, respectively. In conclusion, Tat-CX3 CL1(357–395 aa) facilitates functional recovery after ischemic stroke by promoting microglial polarization from M1 to M2. Therefore, the Tat-CX3 CL1(357–395 aa) is a potential therapeutic agent for ischemic stroke.
